Abstract
Purpose
To evaluate tumor-host interface in oral squamous cell carcinoma (OSCC) by the Brandwein-Gensler histological risk score (BG risk score); to assess its association with clinicopathological features and impact on survival outcomes in a contemporary cohort staged as per AJCC 8th edition pTNM classification.
Methods
This retrospective cohort study at a tertiary care centre included 178 cases of OSCC treated by primary surgical resection from 2013 to 2016. Pathological lymph node status, disease-free survival (DFS), overall survival (OS) were assessed.
Results
BG risk score assessment categorized 25 (14%) cases as low-risk, 93 (52%) as intermediate-risk, and 60 (34%) as high-risk. BG risk score category progression from low to intermediate to high risk was associated with an incremental risk of worsening pN status, DFS, and OS. BG risk score categories significantly demarcated 2-year DFS (96% in low-risk, 51.6% in intermediate-risk, 15% in high-risk; p < 0.001) and OS (96% in low-risk, 66.7% in intermediate-risk, 31.3% in high-risk; p < 0.001). On stratified analysis, BG risk score could further demarcate prognosis in early (I/II) and late (III/IV) stage subgroups (p < 0.001). Multivariate analysis indicated the prognostic impact of BG risk score categories to be additional to, and of equal magnitude to, impact of pTNM stage.
Conclusions
BG risk score is a powerful prognostic tool in OSCC additional to pTNM staging. It can enable risk stratification and inform decisions regarding post-surgical adjuvant treatment. It is undertaken with routine histopathological evaluation, with no increased expense or turnaround time. A case is made for its inclusion in OSCC reporting guidelines.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Change history
04 May 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00405-021-06853-y
References
NCCN guidelines version 1.2020, Head and Neck Cancers https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Sinha N, Rigby M, McNeil M et al (2018) The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth. Mod Pathol 31:772–779
Sutton DN, Brown JS, Rogers SN et al (2003) The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30–34
Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167–178
Peltanova B, Raudenska M, Masarik M (2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer 18:63
Duray A, Demoulin S, Hubert P, Delvenne P, Saussez S (2010) Immune Suppression in Head and Neck Cancers: A Review. J Immunol Res 2010:701657
Ridge JA, Lydiatt WM, Patel SG et al (2017) Lip and Oral Cavity. In: Amin MB (ed) AJCC Cancer Staging Manual 8th Edition 2017. American Joint Committee on Cancer, Chicago, pp 79–94
Seethala RR, Weinreb I, Bullock MJ, et al. Protocol for the Examination of Specimens from Patients with Cancers of the Lip and Oral Cavity. Available at https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates
Brandwein-Gensler M, Smith RV, Wang B et al (2010) Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 34:676–688
Chaturvedi A, Husain N, Misra S et al (2020) Validation of the Brandwein Gensler risk model in patients of oral cavity squamous cell carcinoma in North India. Head Neck Pathol 14:616–622
Li Y, Bai S, Brandwein-Gensler M (2013) Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol 7:211–223
Vered M, Dayan D, Dobriyan A et al (2010) Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136:1039
de Matos FR, Lima Ed, Queiroz LM, da Silveira EJ (2012) Analysis of inflammatory infiltrate, perineural invasion, and risk score can indicate concurrent metastasis in squamous cell carcinoma of the tongue. J Oral Maxillofac Surg 70:1703–1710
Bell RB, Kademan D, Homer L et al (2007) Is there a difference in survival in tongue cancer compared with other subsites in the oral cavity? J Oral Maxillofac Surg 65:229–236
Murthy V, Agarwal JP, Laskar SG et al (2010) Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy. J Cancer Res Ther 6:282–289
Nair S, Singh B, Pawar PV et al (2016) Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. Eur Arch Otorhinolaryngol 273:3921–3928
D’Cruz AK, Sharma S, Agarwal JP et al (2015) Indian Council of Medical Research consensus document for the management of tongue cancer. Indian J Med Paediatr Oncol 36:140–145
Mann J, Julie D, Mahase SS et al (2019) Elective neck dissection, but not adjuvant radiation therapy, improves survival in stage I and II oral tongue cancer with depth of invasion >4 mm. Cureus 11:e6288
Parekh D, Kukreja P, Mallick I, Roy P (2020) Worst pattern of invasion – type 4 (WPOI-4) and Lymphocyte host response should be mandatory reporting criteria for oral cavity squamous cell carcinoma: A re-look at the American Joint Committee of Cancer (AJCC) minimum dataset. Indian J Pathol Microbiol 63:527–533
Yue LE, Sharif KF, Sims JR et al (2020) Oral squamous carcinoma: Aggressive tumor pattern of invasion predicts direct mandible invasion. Head Neck 42:3171–3178
Rath GK, Parikh PM, Hukku S et al (2014) Indian Council of Medical Research consensus document for the management of Buccal mucosa cancers. Indian J Med Paediatr Oncol 35:136–139
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
None of the authors have any conflict of interest to declare.
Ethical approval
Approved by institute ethical committee.
Consent for publication
All authors have approved the manuscript.
Authorship
All authors contributed to the study conception and design. Clinical material preparation, data collection and analysis were performed by Rishikesh Thakur, Alok Thakar and Atul Sharma. Histopathological material preparation and analysis were performed by Aanchal Kakkar. Statistical analysis was performed by Rajeev K. Malhotra. All authors read and approved the final manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Thakur, R., Thakar, A., Malhotra, R.K. et al. Tumor-host interface in oral squamous cell carcinoma: Impact on nodal metastasis and prognosis. Eur Arch Otorhinolaryngol 278, 5029–5039 (2021). https://doi.org/10.1007/s00405-021-06756-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06756-y